• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估高脂血症患者的应激性高血糖比值以预测全因死亡率:一项回顾性队列研究。

Assessing the stress hyperglycemia ratio in hyperlipidemia patients to predict all-cause mortality: A retrospective cohort study.

作者信息

Hu Biao, Yang Zhandong, Yuan Lu, Huang Supu, Huang Xiuli, Wang Chudong, Cai Jiaxin

机构信息

Department of Radiology, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China; Guangzhou Medical University, Guangzhou 511436, China.

Guangzhou Medical University, Guangzhou 511436, China.

出版信息

Diabetes Res Clin Pract. 2025 Aug;226:112301. doi: 10.1016/j.diabres.2025.112301. Epub 2025 May 31.

DOI:10.1016/j.diabres.2025.112301
PMID:40456413
Abstract

BACKGROUND

The Stress Hyperglycemia Ratio (SHR) reflects stress-related hyperglycemia and is linked to poor outcomes in various diseases. This study explores the association between SHR and all-cause mortality in hyperlipidemia patients and its value in enhancing predictive models.

METHODS

Data from the Medical Information Mart for Intensive Care IV (MIMIC-IV) included 4,883 first-admission hyperlipidemia patients. Patients were grouped by SHR quartiles. Outcomes included in-hospital, ICU, and 28-day mortality. Cox regression, restricted cubic spline (RCS), and ROC curves were used. Seventeen machine learning models assessed SHR's predictive value, with LightGBM evaluating variable importance.

RESULTS

We extracted data from 4,883 first-admission hyperlipidemia patients aged 18-100 years (mean age 70 ± 12.1; 36.0 % female). SHR was independently associated with ICU mortality (HR = 1.29, 95 % CI 1.08-1.56), in-hospital mortality (HR = 1.24, 95 % CI 1.07-1.44), and 28-day mortality (HR = 1.32, 95 % CI 1.15-1.52). RCS analysis showed a linear association between SHR and mortality. Adding SHR to general models improved predictive accuracy.

CONCLUSION

In the study of first-admission hyperlipidemia patients, elevated SHR levels were significantly associated with in-hospital, ICU, and 28-day all-cause mortality. Incorporating SHR into existing models enhances their predictive ability, holding significant clinical value for identifying high-risk patients.

摘要

背景

应激性高血糖比值(SHR)反映了与应激相关的高血糖,并且与多种疾病的不良预后相关。本研究探讨了SHR与高脂血症患者全因死亡率之间的关联及其在增强预测模型中的价值。

方法

重症监护医学信息集市IV(MIMIC-IV)的数据包括4883例首次入院的高脂血症患者。患者按SHR四分位数分组。结局包括住院、重症监护病房(ICU)和28天死亡率。使用Cox回归、受限立方样条(RCS)和ROC曲线。17种机器学习模型评估了SHR的预测价值,LightGBM评估变量重要性。

结果

我们从4883例年龄在18至100岁(平均年龄70±12.1岁;女性占36.0%)的首次入院高脂血症患者中提取了数据。SHR与ICU死亡率(HR = 1.29,95%CI 1.08 - 1.56)、住院死亡率(HR = 1.24,95%CI 1.07 - 1.44)和28天死亡率(HR = 1.32,95%CI 1.15 - 1.52)独立相关。RCS分析显示SHR与死亡率之间存在线性关联。将SHR添加到一般模型中可提高预测准确性。

结论

在首次入院高脂血症患者的研究中,SHR水平升高与住院、ICU和28天全因死亡率显著相关。将SHR纳入现有模型可增强其预测能力,对识别高危患者具有重要的临床价值。

相似文献

1
Assessing the stress hyperglycemia ratio in hyperlipidemia patients to predict all-cause mortality: A retrospective cohort study.评估高脂血症患者的应激性高血糖比值以预测全因死亡率:一项回顾性队列研究。
Diabetes Res Clin Pract. 2025 Aug;226:112301. doi: 10.1016/j.diabres.2025.112301. Epub 2025 May 31.
2
Elevated stress hyperglycemia ratio associated with higher hospital mortality in patients with respiratory failure.呼吸衰竭患者中应激性高血糖比率升高与较高的医院死亡率相关。
Sci Rep. 2025 Jul 31;15(1):27972. doi: 10.1038/s41598-025-12853-3.
3
Stress hyperglycemia ratio as a biomarker for early mortality risk stratification in cardiovascular disease: a propensity-matched analysis.应激性高血糖比值作为心血管疾病早期死亡风险分层的生物标志物:一项倾向匹配分析。
Cardiovasc Diabetol. 2025 Jul 12;24(1):286. doi: 10.1186/s12933-025-02812-7.
4
Increased Stress Hyperglycemia Ratio Predicts Poor Clinical Outcome in Critically Ill COPD Patients: A Retrospective Study.应激性高血糖比率升高预示重症慢性阻塞性肺疾病患者临床预后不良:一项回顾性研究
Int J Chron Obstruct Pulmon Dis. 2025 Apr 24;20:1203-1215. doi: 10.2147/COPD.S520418. eCollection 2025.
5
Association between stress hyperglycemia ratio and all-cause mortality in critically ill patients with sepsis: results from the MIMIC-IV database.脓毒症危重症患者应激性高血糖比值与全因死亡率的关联:来自MIMIC-IV数据库的结果
Eur J Med Res. 2025 Jan 21;30(1):42. doi: 10.1186/s40001-025-02281-4.
6
Association between trajectory of triglyceride-glucose index and all-cause mortality in critically ill patients with atrial fibrillation: a retrospective cohort study.甘油三酯-葡萄糖指数轨迹与危重心房颤动患者全因死亡率的关联:一项回顾性队列研究
Cardiovasc Diabetol. 2025 Jul 10;24(1):278. doi: 10.1186/s12933-025-02838-x.
7
U-shaped association of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with NAFLD: results from the NHANES database prospective cohort study.非酒精性脂肪性肝病患者全因死亡率和心血管死亡率的应激性高血糖比值呈U形关联:来自美国国家健康与营养检查调查(NHANES)数据库前瞻性队列研究的结果
BMC Gastroenterol. 2025 Jul 1;25(1):477. doi: 10.1186/s12876-025-04082-9.
8
Association between stress hyperglycemia ratio (SHR) and the risk of acute kidney injury in patients with chronic kidney disease: analysis of the MIMIC-IV database.慢性肾脏病患者应激性高血糖比值(SHR)与急性肾损伤风险的关联:MIMIC-IV数据库分析
BMC Nephrol. 2025 Jul 1;26(1):310. doi: 10.1186/s12882-025-04212-1.
9
Relationship between stress hyperglycemia ratio and the incidence of atrial fibrillation in patients after coronary artery bypass grafting: a retrospective study based on the MIMIC-IV database.冠状动脉搭桥术后患者应激性高血糖比值与心房颤动发生率的关系:一项基于MIMIC-IV数据库的回顾性研究
Diabetol Metab Syndr. 2025 Jul 11;17(1):261. doi: 10.1186/s13098-025-01832-3.
10
The Stress Hyperglycemia Ratio as a Predictor of Clinical Outcomes in Acute Pancreatitis: A Retrospective Cohort Study.应激性高血糖比值作为急性胰腺炎临床结局的预测指标:一项回顾性队列研究
J Clin Med. 2025 Jul 14;14(14):4970. doi: 10.3390/jcm14144970.

引用本文的文献

1
Prognostic value of triglyceride-glucose index combined with stress hyperglycemia ratio for all-cause mortality in critically ill patients with stroke.甘油三酯-葡萄糖指数联合应激性高血糖比率对重症脑卒中患者全因死亡率的预后价值
Cardiovasc Diabetol. 2025 Aug 18;24(1):337. doi: 10.1186/s12933-025-02901-7.